Veracyte (VCYT) Notes Payables (2012 - 2013)

Veracyte (VCYT) posted quarterly Notes Payables of $2.7 million for Q2 2013, up 350.0% on a QoQ basis from $600000.0 in Q4 2012.

Veracyte (VCYT) Notes Payables (2012 - 2013) Analysis & Trends

Veracyte has reported Notes Payables for 2 years, with the latest figure at $2.7 million in Q2 2013.

  • Notes Payables for Q2 2013 came in at $2.7 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2013 was $2.7 million (changed N/A YoY), and the FY2012 annual result was $600000.0, changed N/A from the prior year.
  • Notes Payables improved to $2.7 million in Q2 2013, from $600000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $2.7 million in Q2 2013 and troughed at $600000.0 in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Veracyte 3.69 Bn 3.39 Bn 108.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2013 175,000.00
Dec 31, 2012 600,000.00